Compare GE Vernova Inc (GEV) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs Mesoblast Limited — how do they compare? GE Vernova Inc trades at $1,043.73 (market cap $269.50B), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: GE Vernova Inc is far larger — about 121.9× Mesoblast Limited's market cap, and GE Vernova Inc pays a 0.2% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| GEV | MESO | |
|---|---|---|
Market Cap | $269.50B | $2.21B |
Sector | Technology | Technology |
52-Week High | $1.17K | $20.96 |
52-Week Low | $547.96 | $12.88 |
Enterprise Value | $259.17B | $2.21B |
Dividend Yield | 0.2% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
